Literature DB >> 11290779

Activating Ly-49 NK receptors: central role in cytokine and chemokine production.

J R Ortaldo1, E W Bere, D Hodge, H A Young.   

Abstract

In an attempt to understand potential novel functions of receptors in vivo, we evaluated gene expression after cross-linking the activating Ly-49D mouse NK receptor. Gene expression was evaluated using a mouse GEM 2 microarray chip (Incyte Genomics, St. Louis, MO). Each chip displays a total of 8734 elements. The strongly induced genes fell into two categories: 1) soluble factors and 2) apoptotic genes. The majority of the strongly induced mRNAs as analyzed by microarray hybridization were chemokine genes. RNase protection assays and chemokine protein production analysis validated the microarray results, as cross-linking the Ly-49D mouse NK receptor induced high levels of IFN-gamma, lymphotactin, macrophage-inflammatory protein (MIP)1alpha, and MIP1beta. This gene expression was specific because other chemokines were not induced by anti-Ly-49D receptors. In addition, a series of pharmacological inhibitors were used to identify the key signaling pathways involved in the cellular response. The primary Ly-49D signaling for IFN-gamma production is predominantly mediated through Src kinase pathways involving membrane proximal events, whereas MIP1alpha and MIP1beta gene induction is more complex and may involve multiple biochemical pathways. Thus, we conclude that a primary role for the activating NK receptors in vivo may be to trigger soluble factor production and regulation of the immune response. This would place NK cells and their activating Ly-49 receptors as important initiators of microbial immunity and key elements of the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290779     DOI: 10.4049/jimmunol.166.8.4994

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production.

Authors:  David G T Hesslein; Rayna Takaki; Michelle L Hermiston; Arthur Weiss; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

2.  LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction.

Authors:  Olga Atochina; Donald Harn
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control.

Authors:  Deborah L Hodge; Alfredo Martinez; John G Julias; Lynn S Taylor; Howard A Young
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

4.  MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.

Authors:  Brigitte G Dorner; Alexander Scheffold; Michael S Rolph; Martin B Huser; Stefan H E Kaufmann; Andreas Radbruch; Inge E A Flesch; Richard A Kroczek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

5.  Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection.

Authors:  Tetsuro Sekiguchi; Takeaki Nagamine; Hitoshi Takagi; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

6.  MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways.

Authors:  Ryan P Sullivan; Leslie A Fogel; Jeffrey W Leong; Stephanie E Schneider; Rachel Wong; Rizwan Romee; To-Ha Thai; Veronika Sexl; Scot J Matkovich; Gerald W Dorn; Anthony R French; Todd A Fehniger
Journal:  J Immunol       Date:  2013-11-13       Impact factor: 5.422

7.  A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.

Authors:  Nicholas D Huntington; Yuekang Xu; Stephen L Nutt; David M Tarlinton
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

8.  In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity.

Authors:  Michaela Prchal-Murphy; Agnieszka Witalisz-Siepracka; Karoline T Bednarik; Eva Maria Putz; Dagmar Gotthardt; Katrin Meissl; Veronika Sexl; Mathias Müller; Birgit Strobl
Journal:  Oncoimmunology       Date:  2015-05-26       Impact factor: 8.110

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.